Literature DB >> 11972983

Smallpox vaccination techniques; from knives and forks to needles and pins.

Derrick Baxby1.   

Abstract

Factors affecting the development of smallpox vaccination techniques are discussed and 11 different techniques for inoculating the vaccine are identified and described. The earliest, the simple cut or scratch, was already widely used for smallpox inoculation (variolation). Later, when it became evident that Jenner's claim of lifelong protection was not being achieved parallel, cross-hatched and rotatory methods which produced more severe reactions were introduced, often at more than one site. These methods were then discontinued and even prohibited in some countries, when improved vaccine quality resulted in excessively-severe reactions with such techniques. They were replaced by improved methods such as multiple pressure and multiple puncture with the bifurcated needle, both of which were used extensively. However, the simple scratch method remained popular until the end of the vaccination era. Although the instruments used are not discussed in detail, representative examples of the wide variety used at various times and for the various techniques are illustrated. Again, the simplest and earliest designs remained in use throughout.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11972983     DOI: 10.1016/s0264-410x(02)00028-2

Source DB:  PubMed          Journal:  Vaccine        ISSN: 0264-410X            Impact factor:   3.641


  15 in total

Review 1.  Intradermal vaccination using the novel microneedle device MicronJet600: Past, present, and future.

Authors:  Yotam Levin; Efrat Kochba; Ivan Hung; Richard Kenney
Journal:  Hum Vaccin Immunother       Date:  2015       Impact factor: 3.452

Review 2.  Immunogenicity, safety and tolerability of intradermal influenza vaccines.

Authors:  Ivan F N Hung; Kwok-Yung Yuen
Journal:  Hum Vaccin Immunother       Date:  2017-07-06       Impact factor: 3.452

3.  Vaccination with a codon-optimized A27L-containing plasmid decreases virus replication and dissemination after vaccinia virus challenge.

Authors:  Osmarie Martínez; Ariana Bravo Cruz; Saritza Santos; Maite Ramírez; Eric Miranda; Joanna Shisler; Miguel Otero
Journal:  Vaccine       Date:  2017-06-16       Impact factor: 3.641

Review 4.  Hepatitis B vaccine by intradermal route in non responder patients: an update.

Authors:  Martina Filippelli; Elena Lionetti; Alessia Gennaro; Angela Lanzafame; Teresa Arrigo; Carmelo Salpietro; Mario La Rosa; Salvatore Leonardi
Journal:  World J Gastroenterol       Date:  2014-08-14       Impact factor: 5.742

5.  Enabling skin vaccination using new delivery technologies.

Authors:  Yeu-Chun Kim; Mark R Prausnitz
Journal:  Drug Deliv Transl Res       Date:  2011-02-01       Impact factor: 4.617

6.  Immunization by vaccine-coated microneedle arrays protects against lethal influenza virus challenge.

Authors:  Qiyun Zhu; Vladimir G Zarnitsyn; Ling Ye; Zhiyuan Wen; Yulong Gao; Lei Pan; Ioanna Skountzou; Harvinder S Gill; Mark R Prausnitz; Chinglai Yang; Richard W Compans
Journal:  Proc Natl Acad Sci U S A       Date:  2009-04-27       Impact factor: 11.205

7.  Transcutaneous vaccination via laser microporation.

Authors:  Richard Weiss; Michael Hessenberger; Sophie Kitzmüller; Doris Bach; Esther E Weinberger; Wolf D Krautgartner; Cornelia Hauser-Kronberger; Bernard Malissen; Christof Boehler; Yogeshvar N Kalia; Josef Thalhamer; Sandra Scheiblhofer
Journal:  J Control Release       Date:  2012-06-29       Impact factor: 9.776

Review 8.  Delivery systems for intradermal vaccination.

Authors:  Y C Kim; C Jarrahian; D Zehrung; S Mitragotri; M R Prausnitz
Journal:  Curr Top Microbiol Immunol       Date:  2012       Impact factor: 4.291

9.  Alfred Russel Wallace and the antivaccination movement in Victorian England.

Authors:  Thomas P Weber
Journal:  Emerg Infect Dis       Date:  2010-04       Impact factor: 6.883

Review 10.  Laser microporation of the skin: prospects for painless application of protective and therapeutic vaccines.

Authors:  Sandra Scheiblhofer; Josef Thalhamer; Richard Weiss
Journal:  Expert Opin Drug Deliv       Date:  2013-02-21       Impact factor: 6.648

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.